Neville J. Butcher

St Lucia
QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Predicting clinical efficacy of lung gene delivery in people with cystic fibrosis: which in vitro and in vivo models best predict outcomes in human lungs?

Predicting clinical efficacy of lung gene delivery in people with cystic fibrosis: which in vitro and in vivo models best predict outcomes in human lungs?

Journal: Expert opinion on drug delivery

Published: June 04, 2026

Inhalable gene and RNA therapy for cystic fibrosis: perspectives and progress in clinical development.

Inhalable gene and RNA therapy for cystic fibrosis: perspectives and progress in clinical development.

Journal: Nanomedicine (London, England)

Published: March 23, 2026

The Isolated Thumb Domain of Acid-Sensing Ion Channels Forms a Minimal Folding Unit Enabling Ligand Binding Studies.

The Isolated Thumb Domain of Acid-Sensing Ion Channels Forms a Minimal Folding Unit Enabling Ligand Binding Studies.

Journal: Angewandte Chemie (International ed. in English)

Published: October 30, 2025

The nanobody Nb.C1 potentiates human acid-sensing ion channel 1a and 1b.

The nanobody Nb.C1 potentiates human acid-sensing ion channel 1a and 1b.

Journal: European journal of pharmacology

Published: October 27, 2025

Arylamine N-acetyltransferase 1 expression predicts glucose dependence and mitochondrial bioenergetics in cancer cells.

Arylamine N-acetyltransferase 1 expression predicts glucose dependence and mitochondrial bioenergetics in cancer cells.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: December 02, 2024

Small Molecule Inhibitors of Arylamine N-Acetyltransferase 1 Attenuate Cellular Respiration.

Small Molecule Inhibitors of Arylamine N-Acetyltransferase 1 Attenuate Cellular Respiration.

Journal: ACS pharmacology & translational science

Published: May 14, 2024

Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinity.

Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinity.

Journal: Biomaterials science

Published: April 29, 2024

Lipidated brush-PEG polymers as low molecular weight pulmonary drug delivery platforms.

Lipidated brush-PEG polymers as low molecular weight pulmonary drug delivery platforms.

Journal: Expert opinion on drug delivery

Published: January 22, 2024

The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction.

The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction.

Journal: Pharmacological reviews

Published: August 30, 2023

Dose-Dependent Effect of Phenothiazines as Dynamin II Inhibitors on the Uptake of PEGylated Liposomes by Endocytic Cells and In Vivo Pharmacokinetics of PEGylated Liposomal Doxorubicin in Rats.

Dose-Dependent Effect of Phenothiazines as Dynamin II Inhibitors on the Uptake of PEGylated Liposomes by Endocytic Cells and In Vivo Pharmacokinetics of PEGylated Liposomal Doxorubicin in Rats.

Journal: Molecular pharmaceutics

Published: August 07, 2023

Utilization of endogenous albumin trafficking pathways in the lungs has potential to modestly increase the lung interstitial access and absorption of drug delivery systems after inhaled administration.

Utilization of endogenous albumin trafficking pathways in the lungs has potential to modestly increase the lung interstitial access and absorption of drug delivery systems after inhaled administration.

Journal: Expert opinion on drug delivery

Published: August 03, 2023

Contrasting Effects of Temperature on Human Arylamine N-Acetyltransferase and Acetyl Coenzyme A Hydrolase Activities.

Contrasting Effects of Temperature on Human Arylamine N-Acetyltransferase and Acetyl Coenzyme A Hydrolase Activities.

Journal: Biochemistry

Published: June 15, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026